DEFERIPRONE MARKET ANALYSIS

Deferiprone MarketSize and Trends

Deferiprone Market Dynamics

Rising incidence of hemochromatosis globally, is propelling growth of the deferiprone market. For instance, according to the American Diabetes Association website, hereditary hemochromatosis is the most widespread single-gene disease among western populations, affecting roughly 1 out of every 200 to 300 people. Moreover, rising prevalence of transfusion-dependent thalassemia among the population is significantly expected to propel demand for deferiprone. For instance, according to the World Health Organization 2008 bulletin, around 1.1% of couples worldwide are at risk for having children with a hemoglobin disorder and 2.7 per 1,000 conceptions record this disorder. However, adverse reactions such as agranulocytosis, chromaturia, nausea, vomiting, and abdominal pain related with the use of deferiprone is expected to hamper the deferiprone market growth. Furthermore, increasing healthcare initiatives and funding by government and private agencies is expected to boost growth of the deferiprone market. For instance, according to the article published in PLOS One Journal 2017, UAE government adopted a new nationwide campaign to indorse the premarital screening in 2008. Since its inception, the premarital screening has been mandatory for all married couples in the UAE, which provide information about the risk of conceiving a child suffering from thalassemia

Market- Trends

Rising incidence of hemochromatosis globally, is propelling growth of the deferiprone market. For instance, according to the American Diabetes Association website, hereditary hemochromatosis is the most widespread single-gene disease among western populations, affecting roughly 1 out of every 200 to 300 people. Moreover, rising prevalence of transfusion-dependent thalassemia among the population is significantly expected to propel demand for deferiprone. For instance, according to the World Health Organization 2008 bulletin, around 1.1% of couples worldwide are at risk for having children with a hemoglobin disorder and 2.7 per 1,000 conceptions record this disorder.